At AUA 2018 today, Dornier MedTech announced the launch of Dornier Delta® III SmartLitho™, which offers an analytic algorithm to help urologists make treatment decisions. The new Dornier Delta® III SmartLitho™ can utilize Dornier’s proprietary analytic algorithm, which is able to provide real world data from extracorporeal shock wave lithotripsy (ESWL) treatments of urological stones by validating against a broad set of data points collected globally. The novel algorithm enables urologists to make personalized, evidence-based decisions by assessing historical success rates of treatment modalities as well as identify and balance costs.